Last updated on May 2019

Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Polymyalgia Rheumatica | Giant Cell Arteritis
  • Age: Between 50 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Age older than 50 years
  • Fulfilling ACR/EULAR criteria
  • Disease duration6 months
  • No steroid since 2 weeks prior randomization
  • PMR-AS 17
  • Absence of signs or symptoms of other musculoskeletal or connective tissue conditions
  • Able to give informed consent
  • Concomitant treatments with methotrexate or hydroxychloroquine are not permitted.

Exclusion Criteria:

  • Clinical symptoms of giant cell arteritis
  • Uncontrolled high blood pressure or cardiovascular disease
  • Clinical evidence of significant unstable or uncontrolled acute or chronic diseases not due to PMR
  • Planned surgical procedure or medical history, blood abnormalities or any clinical condition that compromises inclusion
  • History of malignant neoplasm within the last 5 years.
  • Current active infection not controlled
  • Detailed exclusion criteria related to prior or concomitant therapy, general safety and laboratory data are reported in the protocol

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.